Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Christopher Ehrlich Insider Profile
4 Followers
Christopher Ehrlich, Director at Biomimetic Therapeutics, holds 889.08K shares in Biomimetic Therapeutics (Ticker: BMTI), holds 1.48M shares in CERo Therapeutics Holdings (Ticker: CERO), holds 178.41K shares in eFFECTOR Therapeutics (Ticker: EFTR). Most recently, Christopher Ehrlich ― shares of Biomimetic Therapeutics on ― for an estimated value of ―.
Christopher Ehrlich Biomimetic Therapeutics (BMTI)Director
Biomimetic Therapeutics (BMTI)
Director
Ranked #93,884 out of 98,187 Corporate Insiders
Profitable Transactions
0 out of 6 Profitable Transactions
Average Return
-62.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Christopher Ehrlich holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Oct 06, 2022 - Oct 06, 2023
Return:-6.20%
The most profitable trade made by Christopher Ehrlich
Christopher Ehrlich's Trading History
Biomimetic Therapeutics
―
―
―
―
eFFECTOR Therapeutics
Oct 06, 2022
Director
Informative Buy
197.22
$8.39K
CERo Therapeutics Holdings
Feb 16, 2024
Director
Uninformative Buy
―
$211.99K
Paratek Pharmaceuticals
Sep 22, 2011
―
Informative Buy
4.96M
$4.42M
List of latest transactions for each holding click on a transaction to see Christopher Ehrlich's performance on stock
You May Also Like
Christopher Ehrlich insider profile FAQ
What is the percentage of profitable transactions made by Christopher Ehrlich?
The percentage of profitable transactions made by Christopher Ehrlich is 0%.
What is the average return per transaction made by Christopher Ehrlich?
The average return per transaction made by Christopher Ehrlich is -62.10%.
What stocks does Christopher Ehrlich hold?
Christopher Ehrlich holds: BMTI, EFTR, CERO, PRTK stocks.
What was Christopher Ehrlich’s latest transaction?
Christopher Ehrlich latest transaction was an Uninformative Buy of ―.
What was Christopher Ehrlich's most profitable transaction?
Christopher Ehrlich’s most profitable transaction was an Informative Buy of EFTR stock on October 6, 2022. The return on the trade was -6.20%.
What is Christopher Ehrlich's role in Biomimetic Therapeutics?
Christopher Ehrlich's role in Biomimetic Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.